Loading company details...
Latest Form 4 (Nov 10, 2026): Esther Rajavelu (Chief Executive Officer and Chief Financial Officer): Sale of 40,851 shares, $42.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Esther Rajavelu, Chief Executive Officer and Chief Financial Officer | Sale | 40,851 | $42.5K |
| Nov 10, 2026 | William Ho | Grant/Award | 100,000 | n/a |
| Aug 6, 2026 | Debra Zack, Chief Medical Officer | Grant/Award | 162,311 | n/a |
| Jun 25, 2026 | Milind Deshpande | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | Kathleen Tregoning | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | Cynthia Smith | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | Patrick V.j.j. Vink | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | Frank E. Thomas | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | Scott Thomas Jackson | Grant/Award | 10,000 | n/a |
| Jun 25, 2026 | John C. Pottage Jr. | Grant/Award | 10,000 | n/a |